Deck, D. H., Jordan, J. M., Holland, T. L., Fan, W., Wikler, M. A., Sulham, K. A., & Ralph Corey, G. (2016). Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting. Infect Dis Ther, 5(3), 363–365. https://doi.org/10.1007/s40121-016-0127-9

Deck, Daniel H., Jennifer M. Jordan, Thomas L. Holland, Weihong Fan, Matthew A. Wikler, Katherine A. Sulham, and G. Ralph Corey. “Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting.” Infect Dis Ther 5, no. 3 (September 2016): 363–65. https://doi.org/10.1007/s40121-016-0127-9.

Deck DH, Jordan JM, Holland TL, Fan W, Wikler MA, Sulham KA, et al. Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting. Infect Dis Ther. 2016 Sep;5(3):363–5.

Deck, Daniel H., et al. “Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting.” Infect Dis Ther, vol. 5, no. 3, Sept. 2016, pp. 363–65. Pubmed, doi:10.1007/s40121-016-0127-9.

Deck DH, Jordan JM, Holland TL, Fan W, Wikler MA, Sulham KA, Ralph Corey G. Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting. Infect Dis Ther. 2016 Sep;5(3):363–365.